EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic/epigenetic effects in NF1 microdeletion syndrome: beyond the haploinsufficiency, looking at the contribution of not deleted genes

Viviana Tritto, Paola Bettinaglio, Eleonora Mangano, Claudia Cesaretti, Federica Marasca, Chiara Castronovo, Roberta Bordoni, Cristina Battaglia, Veronica Saletti, Valeria Ranzani, Beatrice Bodega, Marica Eoli und 2 weitere

Human Genetics · 2024

DOI: 10.1007/s00439-024-02683-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Genetics, 2024. Verfasst von Viviana Tritto und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology and Translational Medicine (BIOMETRA), University of Milan, Segrate, Milan, Italy. Hauptthemen laut MEDLINE: Haploinsufficiency, Neurofibromatosis 1, Epigenesis, Genetic, Chromosome Deletion. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Milano.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

NF1 microdeletion syndrome, accounting for 5–11% of NF1 patients, is caused by a deletion in the NF1 region and it is generally characterized by a severe phenotype. Although 70% of NF1 microdeletion patients presents the same 1.4 Mb type-I deletion, some patients may show additional clinical features. Therefore, the contribution of several pathogenic mechanisms, besides haploinsufficiency of some genes within the deletion interval, is expected and needs to be defined. We investigated an altered expression of deletion flanking genes by qPCR in patients with type-1 NF1 deletion, compared to healthy donors, possibly contributing to the clinical traits of NF1 microdeletion syndrome. In addition, the 1.4-Mb deletion leads to changes in the 3D chromatin structure in the 17q11.2 region. Specifically, this deletion alters DNA-DNA interactions in the regions flanking the breakpoints, as demonstrated by our 4C-seq analysis. This alteration likely causes position effect on the expression of deletion flanking genes. Interestingly, 4C-seq analysis revealed that in microdeletion patients, an interaction was established between the RHOT1 promoter and the SLC6A4 gene, which showed increased expression. We performed NGS on putative modifier genes, and identified two “likely pathogenic” rare variants in RAS pathway, possibly contributing to incidental phenotypic features. This study provides new insights into understanding the pathogenesis of NF1 microdeletion syndrome and suggests a novel pathomechanism that contributes to the expression phenotype in addition to haploinsufficiency of genes located within the deletion.This is a pivotal approach that can be applied to unravel microdeletion syndromes, improving precision medicine, prognosis and patients’ follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HaploinsufficiencyNeurofibromatosis 1Epigenesis, GeneticChromosome DeletionHumansFemaleMaleNeurofibromin 1Chromosomes, Human, Pair 17PhenotypeChildPromoter Regions, Genetic

Substanzen

Neurofibromin 1NF1 protein, human

Autor:innen und Institutionen

  • Department of Medical Biotechnology and Translational Medicine (BIOMETRA), University of Milan, Segrate, Milan, Italy.
  • Institute for Biomedical Technologies (ITB), National Research Council (CNR), Segrate (Milan), Italy.
  • Medical Genetics Unit, Woman-Child-Newborn Department, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.
  • Genome Biology Unit, Istituto Nazionale di Genetica Molecolare (INGM) "Romeo ed Enrica Invernizzi", Milan, Italy.
  • Developmental Neurology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Department of Biosciences (DBS), University of Milan, Milan, Italy.

Förderung

  • Università degli Studi di Milano

Zitieren

APA

Tritto, V., Bettinaglio, P., Mangano, E., Cesaretti, C., Marasca, F., Castronovo, C., Bordoni, R., Battaglia, C., Saletti, V., Ranzani, V., Bodega, B., Eoli, M., Natacci, F., & Riva, P. (2024). Genetic/epigenetic effects in NF1 microdeletion syndrome: beyond the haploinsufficiency, looking at the contribution of not deleted genes. Human Genetics. https://doi.org/10.1007/s00439-024-02683-0

Vancouver

Tritto V, Bettinaglio P, Mangano E, Cesaretti C, Marasca F, Castronovo C, et al. Genetic/epigenetic effects in NF1 microdeletion syndrome: beyond the haploinsufficiency, looking at the contribution of not deleted genes. Human Genetics. 2024. doi:10.1007/s00439-024-02683-0

BibTeX
@article{Tritto2024,
  author = {Tritto, Viviana and Bettinaglio, Paola and Mangano, Eleonora and Cesaretti, Claudia and Marasca, Federica and Castronovo, Chiara and Bordoni, Roberta and Battaglia, Cristina and Saletti, Veronica and Ranzani, Valeria and Bodega, Beatrice and Eoli, Marica and Natacci, Federica and Riva, Paola},
  title = {Genetic/epigenetic effects in NF1 microdeletion syndrome: beyond the haploinsufficiency, looking at the contribution of not deleted genes},
  journal = {Human Genetics},
  year = {2024},
  doi = {10.1007/s00439-024-02683-0}
}
Kostenlos starten →